Literature DB >> 10856854

Extracardiac conduit fontan procedure: early and intermediate results.

G S Haas1, H Hess, M Black, J Onnasch, F W Mohr, J A van Son.   

Abstract

OBJECTIVE: The extracardiac Fontan procedure, as compared with classic atriopulmonary connections, may have the potential for optimizing ventricular and pulmonary vascular function by maximizing the laminar flow principle, by the avoidance of intra-atrial suture lines and cardiac manipulation, and by minimizing cardiopulmonary bypass time. In this study the clinical results of this procedure are assessed.
METHODS: From January 1990 until January 1997, 45 patients (33 males and 12 females) with a median age of 4.0 years (range 2.7-38 years) underwent an extracardiac Fontan procedure for univentricular physiology. The underlying diagnoses included tricuspid atresia (n=19), double-inlet left ventricle (n=11), and complex anomalies (n=15). Forty patients (89%) were in sinus rhythm. The median ventricular ejection fraction was 60%. In 37 patients (82%) the procedure was staged.
RESULTS: Median cardiopulmonary bypass time was 72 min, with a decrease to a median time of 24 min in the last ten patients. Aortic cross-clamping was avoided in 33 patients (73%). The intraoperative Fontan pressure and transpulmonary gradient were low: 13.6+/-3.2 and 8.5+/-3.9 mmHg, respectively. Transient supraventricular tachyarrhythmias were observed in six patients (13%). There was no early or late mortality. At a median follow-up of 64 months (range 26-105 months), 39 patients (87%) were in NYHA class I, four (9%) were in NYHA class II, and two (4%) were in class III. Forty patients (89%) remained in sinus rhythm. The median ventricular ejection fraction was 59%. The median arterial oxygen saturation raised from 82% preoperatively to 97%. Functional class (P=0.02), maintenance of sinus rhythm (P=0.04), and preservation of ventricular function (P=0.05) was superior in patients who were appropriately staged. None of the patients had atrial thrombus, chronic pleural effusions, or protein losing enteropathy.
CONCLUSIONS: In the majority of patients, the extracardiac Fontan procedure, when performed as a staged procedure, provides excellent early and midterm results in terms of quality of life, maintenance of sinus rhythm, and preservation of ventricular function.

Entities:  

Mesh:

Year:  2000        PMID: 10856854     DOI: 10.1016/s1010-7940(00)00433-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Left innominate vein-pulmonary artery shunt with Glenn anastomosis in a Fontan candidate with central pulmonary artery stenosis.

Authors:  Y Kaneko; Y Hirata; K Yagyu; K Tsuchiya
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

2.  A novel implantation technique for closure of an atypical fenestration connecting the right atrial appendage to an extracardiac conduit by use of a 15 mm Helex device in a patient with total cavopulmonary connection.

Authors:  M Peuster; P Beerbaum
Journal:  Z Kardiol       Date:  2004-10

3.  Magnetic resonance flow analysis of classic and extracardiac Fontan procedures: the seesaw sign.

Authors:  S Bruce Greenberg; W Robert Morrow; Michiaki Imamura; Jonathan Drummond-Webb
Journal:  Int J Cardiovasc Imaging       Date:  2004-10       Impact factor: 2.357

Review 4.  Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis.

Authors:  Chiara Marrone; Gennaro Galasso; Raffaele Piccolo; Francesco de Leva; Rodolfo Paladini; Federico Piscione; Giuseppe Santoro
Journal:  Pediatr Cardiol       Date:  2010-10-22       Impact factor: 1.655

Review 5.  The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.

Authors:  Ganesh K Gnanappa; David S Celermajer; Gary F Sholler; Tom Gentles; David Winlaw; Yves d'Udekem; Julian Ayer
Journal:  Pediatr Cardiol       Date:  2016-10-27       Impact factor: 1.655

Review 6.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

Review 7.  The impact of altitude on early outcome following the Fontan operation.

Authors:  Amir-Reza D Hosseinpour; Catherine Sudarshan; Paul Davies; Samer A M Nashef; David J Barron; William J Brawn
Journal:  J Cardiothorac Surg       Date:  2006-10-02       Impact factor: 1.637

8.  Intra- or extracardiac Fontan operation? A simple strategy when to do what.

Authors:  Wlodzimierz Kuroczynski; David Senft; Amelie Elsaesser; Christoph Kampmann
Journal:  Arch Med Sci       Date:  2013-03-06       Impact factor: 3.318

9.  Semi-Automatic Planning and Three-Dimensional Electrospinning of Patient-Specific Grafts for Fontan Surgery.

Authors:  Xiaolong Liu; Byeol Kim; Yue-Hin Loke; Paige Mass; Laura Olivieri; Narutoshi Hibino; Mark Fuge; Axel Krieger
Journal:  IEEE Trans Biomed Eng       Date:  2021-12-23       Impact factor: 4.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.